847615-14-9
847615-14-9 structure
- Name: tert-butyl 4-(4-bromophenyl)-4-cyanopiperidine-1-carboxylate
- Chemical Name: tert-butyl 4-(4-bromophenyl)-4-cyanopiperidine-1-carboxylate
- CAS Number: 847615-14-9
- Molecular Formula: C17H21BrN2O2
- Molecular Weight: 365.265
- Create Date: 2018-12-27 17:02:09
- Modify Date: 2024-01-29 07:19:20
| Name | tert-butyl 4-(4-bromophenyl)-4-cyanopiperidine-1-carboxylate |
|---|---|
| Synonyms |
TERT-BUTYL 4-CYANO-4-(4-BROMOROPHENYL)PIPERIDINE-1-CARBOXYLATE
4-(4-Bromophenyl)-4-cyanopiperidine-1-carboxylic acid tert-butyl ester 1-BOC-4-CYANO-4-(4-BROMOPHENYL)-PIPERIDINE |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 461.2±45.0 °C at 760 mmHg |
| Molecular Formula | C17H21BrN2O2 |
| Molecular Weight | 365.265 |
| Flash Point | 232.7±28.7 °C |
| Exact Mass | 364.078644 |
| PSA | 53.33000 |
| LogP | 3.46 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.577 |
|
~%
847615-14-9 |
| Literature: Mitsubishi Tanabe Pharma Corporation Patent: EP1956009 A1, 2008 ; Location in patent: Page/Page column 99 ; |
|
~%
847615-14-9 |
| Literature: ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2006/136830 A1, 2006 ; Location in patent: Page/Page column 182-183 ; WO 2006/136830 A1 |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |